Fiona leads a group of cellular and molecular scientists in Biosciences who are inventing new methods and applications for the life sciences industry, including new cell therapy workflows, forensics, synthetic biology and cell imaging.
For the last 10 years, she also led a multidisciplinary program and collaborations to develop a multiplexed imaging platform for fixed tissue, which has led to new insights into tumor biology and immune response. It has been commercialized by GE Healthcare as a service and research platform (MultiOmyx and Cell DIVE). She is Principal Investigator on a NIH RO1 which is investigating apoptosis heterogeneity in colorectal cancer and co-PI with Indiana University which aims to characterize immune response to DCIS. Earlier in her career she led research on osteoporosis, bone health and vitamin D metabolism for the UK MRC and Nestle Research. She has 13 patents and 32 publications.
Fiona has a B.S. Microbiology from National University of Ireland, Galway and Ph.D. in Nutritional Science from University College Cork, Ireland.
..our dynamic teams combine expertise in biology with engineering, math and computer science ..building groundbreaking technologies and tools for analyzing and interrogating disease.
Post-doc at Nestle Research Center, Switzerland, and my first patent in nutrition applications for bone health
2003Leading research programs on dietary, genetic and lifestyle factors modifying bone development during adolescence at MRC Cambridge
Leading a new pathology platform for biomarker analysis in cancer tissue at GE Research
2014Completion of technology transfer to GEHC and commercialization - MultiOmyx
Awarded 5 year NIH RO1 to investigate role of tumor cell heterogeneity in patient prognosis in colorectal cancer
Just for fun
Montreal is one of my favorite cities for it's unique Quebecois history, culture and food. The annual Formula 1 race in June is the ideal intersection of extreme technology, competition and fun. Go Ferrari!